Enhanced type I IFN response observed in AT, Artemis deficiency and SAVI, exert tissue damage through neutrophil-driven chronic processes, providing a common target to manage inflammatory syndromes in diseases with active type I IFN signature.
http://ift.tt/2zLG0Zw
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου